Literature DB >> 6221997

Mechanism of immunosuppression in leprosy: presence of suppressor factor(s) from macrophages of lepromatous patients.

P R Salgame, P R Mahadevan, N H Antia.   

Abstract

Human peripheral blood mononuclear cell proliferation induced by Mycobacterium leprae could be inhibited by the suppressor factor in the lysate of the macrophages of lepromatous leprosy patients. Macrophages from normal subjects and tuberculoid patients did not show production of a suppressor factor. Inhibition occurred only when the factor was present in the initial stages of lymphocyte culture. The factor is heat stable and nondialyzable. Proliferation induced by some mycobacteria and concanavalin A could also be blocked by the factor. Interestingly, blastogenic response by a few other antigens and phytohemagglutinin could not be inhibited by the suppressor factor. Mononuclear cells pretreated with such lysate from lepromatous macrophages for 24 h could induce suppressive activity in the cells in vitro in an autologous system. Treatment of these cells with carbonyl iron after the induction phase, to remove phagocytic cells, did not abolish their suppressive activity. The lepromatous macrophage lysate also generated suppressive activity in a T-lymphocyte-enriched population of normal subjects. These studies are interpreted to indicate that immunosuppression in lepromatous patients is produced by both macrophages and T lymphocytes. The exact phase in which either of these cells acts as a suppressor may be different. Specific suppression by macrophages to M. leprae can be an early event, and nonspecific suppression by T lymphocytes may be a later event in the course of lepromatous leprosy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6221997      PMCID: PMC348166          DOI: 10.1128/iai.40.3.1119-1126.1983

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  21 in total

1.  Inhibition of 3H-thymidine incorporation of lymphocytes by a soluble factor from macrophages.

Authors:  H G Opitz; D Niethammer; H Lemke; H D Flad; R Huget
Journal:  Cell Immunol       Date:  1975-04       Impact factor: 4.868

2.  Immunosuppression in man: suppression by macrophages can be mediated by interactions with regulatory T cells.

Authors:  J D Stobo
Journal:  J Immunol       Date:  1977-09       Impact factor: 5.422

3.  BCG-induced suppressor cells. I. Demonstration of a macrophage-like suppressor cell that inhibits cytotoxic T cell generation in vitro.

Authors:  G R Klimpel; C S Henney
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

4.  Macrophage regulation of DNA synthesis in lymphoid cells: effects of a soluble factor from macrophages.

Authors:  S R Waldman; A A Gottlieb
Journal:  Cell Immunol       Date:  1973-10       Impact factor: 4.868

5.  Influence of chemotherapy and serum factors on the mitogenic response of peripheral leucocytes of leprosy patients to phytohaemagglutinin.

Authors:  V L Mehra; G P Talwar; K Balakrishnan; L K Bhutani
Journal:  Clin Exp Immunol       Date:  1972-10       Impact factor: 4.330

6.  Characterization of the cellular immune defect in lepromatous leprosy: a specific lack of circulating Mycobacterium leprae-reactive lymphocytes.

Authors:  T Godal; B Myklestad; D R Samuel; B Myrvang
Journal:  Clin Exp Immunol       Date:  1971-12       Impact factor: 4.330

7.  Classification of leprosy according to immunity. A five-group system.

Authors:  D S Ridley; W H Jopling
Journal:  Int J Lepr Other Mycobact Dis       Date:  1966 Jul-Sep

8.  An inhibitor of cell proliferation released by cultures of macrophages.

Authors:  J Calderon; R T Williams; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1974-11       Impact factor: 11.205

9.  Thymus-dependent lymphocytes of peripheral blood in leprosy patients.

Authors:  S D Lim; D F Kiszkiss; R R Jacobson; Y S Choi; R A Good
Journal:  Infect Immun       Date:  1974-02       Impact factor: 3.441

10.  Function of macrophages in antigen recognition by guinea pig T lymphocytes. I. Requirement for histocompatible macrophages and lymphocytes.

Authors:  A S Rosenthal; E M Shevach
Journal:  J Exp Med       Date:  1973-11-01       Impact factor: 14.307

View more
  19 in total

1.  Lipids from Mycobacterium leprae cell wall are endowed with an anti-inflammatory property and inhibit macrophage function in vivo.

Authors:  A C Moura; M Mariano
Journal:  Immunology       Date:  1996-12       Impact factor: 7.397

2.  Natural emergence of antigen-reactive T cells in lepromatous leprosy patients during erythema nodosum leprosum.

Authors:  S Laal; L K Bhutani; I Nath
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

Review 3.  Progress in the immunology of the mycobacterioses.

Authors:  G A Rook
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

4.  In vitro generation of adherent mononuclear suppressor cells to Toxoplasma antigen.

Authors:  B J Luft; P W Pedrotti; J S Remington
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

5.  Immunosuppressive macrophages induced by arthropathic peptidoglycan-polysaccharide polymers from bacterial cell walls.

Authors:  D R Regan; P L Cohen; W J Cromartie; J H Schwab
Journal:  Clin Exp Immunol       Date:  1988-12       Impact factor: 4.330

6.  Suppression of T-cell proliferation by Mycobacterium leprae and its products: the role of lipopolysaccharide.

Authors:  A Molloy; G Gaudernack; W R Levis; Z A Cohn; G Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  Mycobacterium leprae fails to stimulate phagocytic cell superoxide anion generation.

Authors:  T J Holzer; K E Nelson; R G Crispen; B R Andersen
Journal:  Infect Immun       Date:  1986-02       Impact factor: 3.441

Review 8.  Leprosy.

Authors:  R C Hastings; T P Gillis; J L Krahenbuhl; S G Franzblau
Journal:  Clin Microbiol Rev       Date:  1988-07       Impact factor: 26.132

9.  In vitro suppression of interleukin 2 production by Mycobacterium leprae antigen.

Authors:  S Makonkawkeyoon; W Kasinrerk
Journal:  Clin Exp Immunol       Date:  1989-06       Impact factor: 4.330

10.  Influence of Mycobacterium leprae and its soluble products on the cutaneous responsiveness of leprosy patients to antigen and recombinant interleukin 2.

Authors:  G Kaplan; E P Sampaio; G P Walsh; R A Burkhardt; T T Fajardo; L S Guido; A de Miranda Machado; R V Cellona; R M Abalos; E N Sarno
Journal:  Proc Natl Acad Sci U S A       Date:  1989-08       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.